Skip to main content
Top
Published in: Cancer Causes & Control 5/2014

01-05-2014 | Original paper

Regional variations in German mesothelioma mortality rates: 2000–2010

Authors: Sara J. Schonfeld, Valerie McCormack, Mark J. Rutherford, Joachim Schüz

Published in: Cancer Causes & Control | Issue 5/2014

Login to get access

Abstract

Purpose

Germany has one of the highest age-adjusted mesothelioma mortality rates worldwide. As mesothelioma occurs ≥30 years after asbestos exposure, contemporary rates likely reflect exposures in the 1960–1970s. During this period, political division between West and East Germany led to differences regarding the import and consumption of asbestos. It is unclear whether mesothelioma rates also differ between these formerly separate countries which are now served by similar health and mortality reporting systems, thereby facilitating regional comparisons.

Methods

We examined regional, temporal, and sex variations in mesothelioma mortality rates in Germany in 2000–2010, collapsing the federal states into West Germany, East Germany, and Berlin. We calculated truncated (≥40 years) age-standardized mesothelioma mortality rates (ASRs40+) per 100,000 person-years, estimated sex-stratified mortality rate ratios (MRRs) (95 % confidence intervals (CIs)), adjusted for age and calendar year from Poisson models, and fitted age–period–cohort models.

Results

There were 12,854 mesothelioma deaths at ages ≥ 40 years in Germany during 2000–2010. ASRs40+ were higher in West (males 4.4; females 0.8) than East (males 1.7; females 0.6) Germany. MRRs for West versus East Germany were 2.68 (95 % CI 2.48–2.88) among males and 1.42 (95 % CI 1.27–1.59) among females. In both regions, mortality rates increased for birth cohorts until the mid 1940s and subsequently declined. The country’s peak mesothelioma burden is predicted to occur by 2020.

Conclusions

Geographical differences in mesothelioma mortality rates are consistent with heterogeneous historical asbestos exposures. Differences may exist for other asbestos-related cancers and should be investigated in analytic studies with individual asbestos exposure information.
Appendix
Available only for authorised users
Literature
1.
go back to reference Boffetta P, Stayner L (2006) Pleural and peritoneal neosplasms. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Oxford, pp 659–673 Boffetta P, Stayner L (2006) Pleural and peritoneal neosplasms. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Oxford, pp 659–673
2.
go back to reference Peto J, Hodgson JT, Matthews FE, Jones JR (1995) Continuing increase in mesothelioma mortality in Britain. Lancet 345(8949):535–539PubMedCrossRef Peto J, Hodgson JT, Matthews FE, Jones JR (1995) Continuing increase in mesothelioma mortality in Britain. Lancet 345(8949):535–539PubMedCrossRef
3.
go back to reference Price B, Ware A (2004) Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 159(2):107–112PubMedCrossRef Price B, Ware A (2004) Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 159(2):107–112PubMedCrossRef
4.
go back to reference Bianchi C, Bianchi T (2007) Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 45(3):379–387PubMedCrossRef Bianchi C, Bianchi T (2007) Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 45(3):379–387PubMedCrossRef
5.
go back to reference Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T (2011) Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 89(10):716–724CPubMedCentralPubMedCrossRef Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T (2011) Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 89(10):716–724CPubMedCentralPubMedCrossRef
6.
go back to reference Jemal A, Grauman D, Devesa S (2000) Recent geographic patterns of lung cancer and mesothelioma mortality rates in 49 shipyard counties in the United States, 1970–1994. Am J Ind Med 37(5):512–521PubMedCrossRef Jemal A, Grauman D, Devesa S (2000) Recent geographic patterns of lung cancer and mesothelioma mortality rates in 49 shipyard counties in the United States, 1970–1994. Am J Ind Med 37(5):512–521PubMedCrossRef
7.
go back to reference Okello C, Treasure T, Nicholson AG, Peto J, Moller H (2009) Certified causes of death in patients with mesothelioma in South East England. BMC Cancer 9:28PubMedCentralPubMedCrossRef Okello C, Treasure T, Nicholson AG, Peto J, Moller H (2009) Certified causes of death in patients with mesothelioma in South East England. BMC Cancer 9:28PubMedCentralPubMedCrossRef
8.
go back to reference Doll R, Cook P (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2(3):269–279PubMedCrossRef Doll R, Cook P (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2(3):269–279PubMedCrossRef
9.
go back to reference Rutherford MJ, Lambert PC, Thompson JR (2010) Age-period-cohort modelling. Stata J 10:602–627 Rutherford MJ, Lambert PC, Thompson JR (2010) Age-period-cohort modelling. Stata J 10:602–627
10.
go back to reference Pisati M (2004) Simple thematic mapping. Stata J 4:361–378 Pisati M (2004) Simple thematic mapping. Stata J 4:361–378
11.
go back to reference Rutherford MJ, Thompson JR, Lambert PC (2012) Projecting cancer incidence using age-period-cohort models incorporating restricted cubic splines. Int J Biostat 8(1):33PubMedCrossRef Rutherford MJ, Thompson JR, Lambert PC (2012) Projecting cancer incidence using age-period-cohort models incorporating restricted cubic splines. Int J Biostat 8(1):33PubMedCrossRef
12.
go back to reference Goldberg S, Rey G, Luce D et al (2010) Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates. Occup Environ Med 67(6):417–421PubMedCrossRef Goldberg S, Rey G, Luce D et al (2010) Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates. Occup Environ Med 67(6):417–421PubMedCrossRef
13.
go back to reference Hagemeyer O, Otten H, Kraus T (2006) Asbestos consumption, asbestos exposure and asbestos-related occupational diseases in Germany. Int Arch Occup Environ Health 79(8):613–620PubMedCrossRef Hagemeyer O, Otten H, Kraus T (2006) Asbestos consumption, asbestos exposure and asbestos-related occupational diseases in Germany. Int Arch Occup Environ Health 79(8):613–620PubMedCrossRef
14.
go back to reference Virta RL (2006) Worldwide asbestos supply and consumption trends from 1900 through 2003 Virta RL (2006) Worldwide asbestos supply and consumption trends from 1900 through 2003
15.
go back to reference Pott F (1994) Asbestos use and carcinogenicity in Germany and a comparison with animal studies. Ann Occup Hyg 38(4):589–600, 420 Pott F (1994) Asbestos use and carcinogenicity in Germany and a comparison with animal studies. Ann Occup Hyg 38(4):589–600, 420
16.
go back to reference Sturm W, Menze B, Krause J, Thriene B (1994) Use of asbestos, health risks and induced occupational diseases in the former East Germany. Toxicol Lett 72(1–3):317–324PubMedCrossRef Sturm W, Menze B, Krause J, Thriene B (1994) Use of asbestos, health risks and induced occupational diseases in the former East Germany. Toxicol Lett 72(1–3):317–324PubMedCrossRef
17.
go back to reference Sturm W, Menze B, Krause J, Thriene B (1995) Asbestos-related diseases and asbestos types used in the former GDR. Exp Toxicol Pathol 47(2–3):173–178PubMedCrossRef Sturm W, Menze B, Krause J, Thriene B (1995) Asbestos-related diseases and asbestos types used in the former GDR. Exp Toxicol Pathol 47(2–3):173–178PubMedCrossRef
18.
go back to reference Arendt M, Blome H, Bonk L et al (2013) Faserjahre. BK-report 1/2013. Deutsche Gesetzliche Unfallversicherung (DGUV), Berlin 2013 Arendt M, Blome H, Bonk L et al (2013) Faserjahre. BK-report 1/2013. Deutsche Gesetzliche Unfallversicherung (DGUV), Berlin 2013
19.
20.
go back to reference IARC (2012) A review of human carcinogens: arsenic, metals, fibres, and dusts. IARC monographs on the evaluation of carcinogenic risks to humans, vol 100 C IARC (2012) A review of human carcinogens: arsenic, metals, fibres, and dusts. IARC monographs on the evaluation of carcinogenic risks to humans, vol 100 C
21.
go back to reference Montanaro F, Bray F, Gennaro V et al (2003) Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 14(8):791–803PubMedCrossRef Montanaro F, Bray F, Gennaro V et al (2003) Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 14(8):791–803PubMedCrossRef
22.
go back to reference Darnton A, Hodgson J, Benson P, Coggon D (2012) Mortality from asbestosis and mesothelioma in Britain by birth cohort. Occup Med (Lond) 62(7):549–552CrossRef Darnton A, Hodgson J, Benson P, Coggon D (2012) Mortality from asbestosis and mesothelioma in Britain by birth cohort. Occup Med (Lond) 62(7):549–552CrossRef
23.
go back to reference Burdorf A, Jarvholm B, Englund A (2005) Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands. Int J Cancer 113(2):298–301PubMedCrossRef Burdorf A, Jarvholm B, Englund A (2005) Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands. Int J Cancer 113(2):298–301PubMedCrossRef
24.
go back to reference Fuchs-Schundeln N, Schundeln M (2009) Who stays, who goes, who returns? East-West migration within Germany since reunification. Econ Transit 17(4):703–738CrossRef Fuchs-Schundeln N, Schundeln M (2009) Who stays, who goes, who returns? East-West migration within Germany since reunification. Econ Transit 17(4):703–738CrossRef
26.
go back to reference Schuz J, Schonfeld SJ, Kromhout H et al (2013) A retrospective cohort study of cancer mortality in employees of a Russian chrysotile asbestos mine and mills: study rationale and key features. Cancer Epidemiol 37(4):440–445PubMedCrossRef Schuz J, Schonfeld SJ, Kromhout H et al (2013) A retrospective cohort study of cancer mortality in employees of a Russian chrysotile asbestos mine and mills: study rationale and key features. Cancer Epidemiol 37(4):440–445PubMedCrossRef
27.
go back to reference Pesch B, Taeger D, Johnen G et al (2010) Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos. Int J Hyg Environ Health 213(1):44–51PubMedCrossRef Pesch B, Taeger D, Johnen G et al (2010) Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos. Int J Hyg Environ Health 213(1):44–51PubMedCrossRef
28.
go back to reference van Kampen V, Merget R, Butz M, Taeger D, Bruning T (2008) Trends in suspected and recognized occupational respiratory diseases in Germany between 1970 and 2005. Am J Ind Med 51(7):492–502PubMedCrossRef van Kampen V, Merget R, Butz M, Taeger D, Bruning T (2008) Trends in suspected and recognized occupational respiratory diseases in Germany between 1970 and 2005. Am J Ind Med 51(7):492–502PubMedCrossRef
Metadata
Title
Regional variations in German mesothelioma mortality rates: 2000–2010
Authors
Sara J. Schonfeld
Valerie McCormack
Mark J. Rutherford
Joachim Schüz
Publication date
01-05-2014
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 5/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0368-4

Other articles of this Issue 5/2014

Cancer Causes & Control 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine